Literature DB >> 7555498

Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.

K W Chen1, E J Boyko, R W Bergstrom, D L Leonetti, L Newell-Morris, P W Wahl, W Y Fujimoto.   

Abstract

OBJECTIVE--To identify risk factors for development of non-insulin-dependent diabetes mellitus (NIDDM) during a 5-year longitudinal follow-up of second-generation Japanese-American (Nisei) men. RESEARCH DESIGN AND METHODS--For 5 years, 137 initially nondiabetic Nisei men were followed with 75-g oral glucose tolerance tests at the initial visit and at 2.5- and 5-year follow-up visits. Body fat distribution was assessed by computed tomography (CT) and body mass index (BMI) calculated at each visit. Fasting insulin and C-peptide, the increment of insulin and C-peptide at 30 min after the oral glucose load, intra-abdominal and total subcutaneous fat by CT, and BMI were compared between those who remained nondiabetic (non-DM) and those who had developed NIDDM at 2.5 years (DM-A) and 5 years (DM-B). RESULTS--At baseline, the DM-A group had significantly increased intra-abdominal fat, elevated fasting plasma C-peptide, and lower C-peptide response at 30 min after oral glucose. At the 2.5-year follow-up, this group had markedly increased fasting plasma insulin and decreased 30-min insulin and C-peptide response to oral glucose. The DM-B group also had significantly lower insulin response at 30 min after oral glucose at baseline but no significant difference in intra-abdominal fat or fasting plasma insulin and C-peptide levels. When this group developed NIDDM by 5-year follow-up, however, an increase of intra-abdominal fat was found superimposed on the pre-existing lower insulin response. Fasting plasma insulin and C-peptide remained low. CONCLUSION--In DM-A, lower 30-min insulin response to oral glucose (an indicator of beta-cell lesion) and increased intra-abdominal fat and fasting C-peptide (indicators of insulin resistance) were the risk factors related to the development of NIDDM. DM-B subjects had a lower 30-min insulin response to oral glucose at baseline and increased intra-abdominal fat at 5-years, when they were found to have NIDDM. Thus, both insulin resistance and impaired beta-cell function contribute to the development of NIDDM in Japanese-Americans, and impaired beta-cell function may be present earlier than visceral adiposity in some who subsequently develop NIDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555498     DOI: 10.2337/diacare.18.6.747

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  35 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

Review 2.  Statin use in the metabolic syndrome.

Authors:  Justin B Lundbye; Paul D Thompson
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

3.  A Prospective Study of Variability in Glycemic Control during Different Phases of the Menstrual Cycle in Type 2 Diabetic Women Using High Sensitivity C - Reactive Protein.

Authors:  T S Gugapriya; S Karthick; B Nagarjuna
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.

Authors:  C Lorenzo; K Williams; S M Haffner
Journal:  Diabet Med       Date:  2012-08       Impact factor: 4.359

5.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Authors:  C Weyer; C Bogardus; D M Mott; R E Pratley
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

Authors:  La-or Chailurkit; Wallaya Jongjaroenprasert; Suwannee Chanprasertyothin; Boonsong Ongphiphadhanakul
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Ambient Volatile Organic Compounds and Racial/Ethnic Disparities in Gestational Diabetes Mellitus: Are Asian/Pacific Islander Women at Greater Risk?

Authors:  Andrew D Williams; Katherine L Grantz; Cuilin Zhang; Carrie Nobles; Seth Sherman; Pauline Mendola
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

8.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

Authors:  A Gastaldelli; E Ferrannini; Y Miyazaki; M Matsuda; R A DeFronzo
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

9.  Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.

Authors:  Jonathan Q Purnell; Steven E Kahn; Mary H Samuels; David Brandon; D Lynn Loriaux; John D Brunzell
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-02       Impact factor: 4.310

Review 10.  Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.

Authors:  Rodrigo Muñoz; Alex Escalona
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.